Philippe Icard
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism 31
- Oncology top 5%
- Cancer-related Molecular Pathways 7
-
- Lung Cancer Diagnosis and Treatment 12
- Pleural and Pulmonary Diseases 8
- Lung Cancer Treatments and Mutations 6
- Molecular Biology top 5%
- Mitochondrial Function and Pathology 11
- Metabolism, Diabetes, and Cancer 10
-
- Cancer Research and Treatments 6
Philippe Icard
84 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Cancer Research 1.6k
- Oncology 724
- Endocrinology, Diabetes and Metabolism 439
- Pulmonary and Respiratory Medicine 795
- Molecular Biology 1.7k
Countries citing papers authored by Philippe Icard
This map shows the geographic impact of Philippe Icard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Icard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Icard more than expected).
Fields of papers citing papers by Philippe Icard
This network shows the impact of papers produced by Philippe Icard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Icard. The network helps show where Philippe Icard may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Philippe Icard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | 2022 | 17 | |
| 3 | 2021 | 19 | |
| 4 | 2020 | 19 | |
| 5 | 2020 | 9 | |
| 6 | 2015 | 13 | |
| 7 | 2013 | 35 | |
| 8 | 2013 | 5 | |
| 9 | 2011 | 129 | |
| 10 | 2010 | 58 | |
| 11 | 2000 | 6 | |
| 12 | 1999 | 12 | |
| 13 | 1999 | 27 | |
| 14 | 1999 | 6 | |
| 15 | 1999 | 35 | |
| 16 | 1999 | 52 | |
| 17 | 1998 | 8 | |
| 18 | 1994 | 64 | |
| 19 | 1992 | 39 | |
| 20 | 1990 | 15 |
About Philippe Icard
Philippe Icard is a scholar working on Cancer Research, Biochemistry, Pulmonary and Respiratory Medicine, Oncology and Biotechnology, having authored 85 papers that have together received 3.8k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (31 papers), Lung Cancer Diagnosis and Treatment (12 papers), Mitochondrial Function and Pathology (11 papers), Metabolism, Diabetes, and Cancer (10 papers), Pleural and Pulmonary Diseases (8 papers), Cancer-related Molecular Pathways (7 papers), Cancer Research and Treatments (6 papers) and Lung Cancer Treatments and Mutations (6 papers). The work is most often cited by research in Cancer Research (1.6k citations), Oncology (724 citations), Endocrinology, Diabetes and Metabolism (439 citations), Pulmonary and Respiratory Medicine (795 citations) and Molecular Biology (1.7k citations). Philippe Icard has collaborated with scholars based in France, Italy and China. Frequent co-authors include Hubert Lincet, Marco Alifano, Zherui Wu, Ludovic Fournel, Jean‐Marc Steyaert, Laurent Poulain, Diana Farhat, S. Shulman, Y Chapuis and B Andréassian. Their work appears in journals such as The Annals of Thoracic Surgery, Drug Resistance Updates, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, European Journal of Cardio-Thoracic Surgery and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.